Healthcare

Vertex SEA Fund V would be almost 50% larger than its 2019-vintage predecessor and will double down on existing investments, PEI understands.

The pressure placed on the healthcare sector over the last two years has spurred a wave of digitalisation, and GPs with the right skill sets could benefit from a slew of opportunities.

Fund II will invest in North American healthcare service companies.

Apps devoted to mental health and wellness captured the imagination of investors during the pandemic, but can the sector hold its momentum?

PE firms continue to vie for assets in the increasingly digitalised healthcare market, but a selective approach is critical if they are to navigate challenges such as regulation and intense competition.

In a high-valuation environment, healthcare investors must push value creation harder than ever, says Guillaume Jabalot, director at Montagu.

An ageing population, an upgrading industry with strong innovation capability and a wave of venture capital investment means the Chinese market is well-positioned for increased healthcare interest, says Legend Capital’s Jafar Wang.

Home and community-based care, behavioural care and speciality pharma offer fresh opportunities for healthcare investors, say The Vistria Group’s co-heads of healthcare Jon Maschmeyer, Amy Christensen and David Schuppan.

Competition in healthcare is intense, but PE firms can succeed if they understand the post-covid ecosystem, say KPMG’s Kristin Pothier and Glenn Mincey.

The pandemic has heightened demand for some healthcare sectors while exposing fragility in others, says 3i director Severin Matten.